<DOC>
<DOCNO> CNN19981201.1130.0399 </DOCNO>
<DOCTYPE> NEWS </DOCTYPE>
<TXTTYPE> CAPTION </TXTTYPE>
<TEXT>
An FDA advisory panel is reviewing a new class of experimental drugs 
this week that could bring relief to people who can't stomach aspirin. 
Called Cox-two inhibitors, the drugs aren't any stronger than aspirin, 
but they're safer for the body. An enzyme in the drugs protects the 
stomach. 
</TEXT>
</DOC>